ArticleExploration of targeted anti-tumor therapy2023
Chimeric single-chain variable fragment-human immunoglobulin G crystallizable fragment antibody against GD2 for neuroblastoma targeted immunotherapy.
Witida Laopajon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.